Three works led by the ICREA investigator Dr. Josep Dalmau among the 25 Lancet Neurology most cited papers

Dr. Josep Dalmau is an ICREA investigator leading the IDIBAPS Autoimmunity against synaptic antigens Group. His international impact is reflected in the fact that three works with Dr. Dalmau as its first author are among the 25 Lancet Neurology most cited papers since 2008. The research conducted by him and his team in Anti-NMDA-receptor encephalitis and paraneoplastic syndromes of the central nervous system have become an international reference.

The list of most cited articles was published by Lanced Neurology using Scopus.

The three articles led by Dr. Dalmau were:

  • Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008 Dec;7(12):1091-8. doi: 10.1016/S1474-4422(08)70224-2. Epub 2008 Oct 11. Read the Abstract
  • Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011 Jan;10(1):63-74. doi: 10.1016/S1474-4422(10)70253-2. Read the Abstract
  • Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS.Lancet Neurol. 2008 Apr;7(4):327-40. doi: 10.1016/S1474-4422(08)70060-7. Read the Abstract